Breaking News Instant updates and real-time market news.

APC

Anadarko

$48.79

-0.2578 (-0.53%)

, LQ

La Quinta

$17.85

0.595 (3.45%)

10:09
10/06/17
10/06
10:09
10/06/17
10:09

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Anadarko (APC) upgraded to Overweight from Neutral at Atlantic Equities. 2. La Quinta (LQ) upgraded to Outperform from Market Perform at Wells Fargo with analyst Jeffrey Donnelly saying he believes the spin-off of La Quinta's real estate to a newly formed REIT in 2018 will lead to the sale of the brand/management to a larger brand company. 3. Kraft Heinz (KHC) upgraded to Overweight from Neutral at Piper Jaffray with analyst Michael Lavery saying he expects the company to make further acquisitions. 4. MorphoSys (MPSYY) upgraded to Overweight from Neutral at JPMorgan with analyst James Gordon saying he believes the company's pipeline optionality is not reflected in the current valuation. 5. Motorola Solutions (MSI) upgraded to Buy from Neutral at Cleveland Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

APC

Anadarko

$48.79

-0.2578 (-0.53%)

LQ

La Quinta

$17.85

0.595 (3.45%)

KHC

Kraft Heinz

$78.25

0.48 (0.62%)

MPSYY

MorphoSys

MSI

Motorola Solutions

$88.75

2.75 (3.20%)

APC Anadarko
$48.79

-0.2578 (-0.53%)

10/06/17
ATLE
10/06/17
UPGRADE
ATLE
Overweight
Anadarko upgraded to Overweight from Neutral at Atlantic Equities
09/21/17
MUFG
09/21/17
NO CHANGE
MUFG
Anadarko buyback a positive signal, says MUFG
MUFG analyst Michael McAllister said in a research note that Anadarko's authorization of a $2.5B share repurchase program, with a year-end goal of executing $1B of the program, signals that Anadarko feels it is "nearing an inflection point where they can start manufacturing free cash flows either next year or in 2019." McAllister reaffirmed his Overweight rating and maintained his $66 price target on Anadarko shares.
08/08/17
DBAB
08/08/17
NO CHANGE
DBAB
Deutsche views Pioneer Natural, peers as 'significantly oversold'
Deutsche Bank analyst Ryan Todd believes Pioneer Natural Resources (PXD) as well as the Permian Exploration & Production space are "significantly oversold" following Pioneer's Q2 results last week. The higher gas content of the production stream started an investor debate around the long-term risks to Permian production and resource value, Todd tells investors in a research note. He calls investor fears "wildly overblown" and is a buyer of the group, especially Pioneer Natural. The analyst has Buy ratings on the shares as well as Anadarko Petroleum (APC), ConocoPhillips (COP), Chevron (CVX) and Devon Energy (DVN).
09/21/17
EVER
09/21/17
NO CHANGE
Target $62
EVER
Outperform
Anadarko $2.5B buyback a positive for E&P stocks, says Evercore ISI
Evercore ISS analyst Stephen Richardson said Anadarko's $2.5B share buyback announcement is a positive for both fundamentals and sentiment surrounding the company, but also for the E&P sector. Richardson said Anadarko is a significant independent E&P and is reacting to the shifting environment while showing growth will not come at any price. The analyst rates shares an Outperform with a $62 price target.
LQ La Quinta
$17.85

0.595 (3.45%)

06/15/17
MSCO
06/15/17
UPGRADE
Target $16
MSCO
Overweight
La Quinta upgraded to Overweight on valuation, lodging demand at Morgan Stanley
As previously reported, Morgan Stanley upgraded La Quinta to Overweight from Equal Weight and increased its price target to $16 from $14. The analyst has a more bullish outlook for lodging demand given the stronger economy and raised La Quinta estimates, and notes shares have underperformed year-to-date.
06/15/17
06/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. La Quinta (LQ) upgraded to Overweight from Equal Weight at Morgan Stanley with the firm's analyst indicating a more bullish outlook for lodging demand given the stronger economy and raised La Quinta estimates, and notes shares have underperformed year-to-date. 2. Paccar (PCAR) upgraded to Buy from Neutral at Goldman Sachs with analyst Jerry Revinch saying he is positive on the company's prospects to further improve its industry-leading returns on capital. 3. Thomson Reuters (TRI) upgraded to Outperform from Neutral at Macquarie with analyst Giasone Salati saying he now believes the company is well positioned for what might be a once-in-a-decade boost in demand for services by MIFID II investment firms. 4. Beazer Homes (BZH) upgraded to Outperform from Neutral at Wedbush with analyst Jay McCanless citing what he sees as "the loosening of credit standards at Fannie Mae (FNMA)." 5. Enterprise Products (EPD) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Tom Abrams citing relative valuation and said the company should benefit from improving ethane markets over the next few years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/06/17
WELS
10/06/17
UPGRADE
Target $22
WELS
Outperform
La Quinta upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo analyst Jeffrey Donnelly upgraded La Quinta to Outperform and $22 price target. The analyst believes the spin-off of La Quinta's real estate to a newly formed REIT in 2018 will lead to the sale of the brand/management to a larger brand company. He estimates the split of La Quinta Holdings into CorePoint Lodging is worth approximately $8.75/share and the new La Quinta could be worth approximately $16/share. Donnelly also raised estimate to account for the positive impact to earnings from recent hurricanes.
06/15/17
MSCO
06/15/17
UPGRADE
MSCO
Overweight
La Quinta upgraded to Overweight from Equal Weight at Morgan Stanley
KHC Kraft Heinz
$78.25

0.48 (0.62%)

10/06/17
PIPR
10/06/17
UPGRADE
Target $90
PIPR
Overweight
Kraft Heinz upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Michael Lavery upgraded Kraft Heinz to Overweight saying he expects the company to make further acquisitions. The recent share pullback in the sector likely makes economics more attractive and may broaden Kraft Heinz's takeover options, Lavery tells investors in a research note partially titled, "Conditions Look Ripe for an Accretive Deal." The analyst sees room for a deal to drive "more meaningful upside in the shares." Lavery lowered his price target for Kraft Heinz shares to $90 from $92.
10/04/17
GSCO
10/04/17
DOWNGRADE
Target $87
GSCO
Neutral
Kraft Heinz downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Jason English downgraded Kraft Heinz (KHC) to Neutral and lowered his price target for the shares to $87 from $95. The analyst sees greater downside risk to estimates than upside with input cost pressure mounting. After updating his estimates across the Americas Consumer Staples group, English sees increasing risk to margin expectations as renewed input cost pressures challenge pricing power. He keeps Sell ratings on J.M. Smucker (SJM), General Mills (GIS), Church & Dwight (CHD) and Procter & Gamble (PG).
10/02/17
SUSQ
10/02/17
NO CHANGE
Target $135
SUSQ
Positive
PepsiCo could be next takeout for AB In Bev, says Susquehanna
Susquehanna analyst Pablo Zuanic noted Pepsico (PEP) reports Q3 on October 3rd and he projects year-to-date metrics and earnings are below consensus. He trimmed his North American sales growth on weaker trends than expected, but he believes the potential miss could already be reflected in the shares. The analyst said based on valuation and fundamentals the stock deserves a Neutral rating but he continues to see it as the next logical target for AB InBev (BUD) in a joint bid with Kraft Heinz (KHC). Zuanic keeps a $135 price target on PepsiCo shares.
08/21/17
ARGS
08/21/17
NO CHANGE
ARGS
Kraft Heinz weakness creates buying opportunity, says Argus
Argus analyst John Eade says that Kraft Heinz's weakness over the past three months has created a buying opportunity. The analyst says that the company can benefit from "strong cost synergies and continued earnings growth."
MPSYY MorphoSys

10/06/17
JPMS
10/06/17
UPGRADE
JPMS
Overweight
MorphoSys upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst James Gordon upgraded MorphoSys to Overweight and raised his price target for the shares EUR 85 from EUR 62. The analyst believes the company's pipeline optionality is not reflected in the current valuation.
MSI Motorola Solutions
$88.75

2.75 (3.20%)

05/26/17
JEFF
05/26/17
NO CHANGE
Target $100
JEFF
Buy
Jefferies feels 'very good' about risk/reward on Motorola Solutions
After looking into the company's business, Jefferies analyst George Notter says he feels "very good" about the risk/reward in shares of Motorola Solutions. The company is not seeing any slowdown in its Federal business, and management tends to set conservative expectations, Notter tells investors in a research note. He's still surprised that the guidance three weeks ago wasn't viewed more positively. The analyst reiterates a Buy rating on Motorola Solutions with a $100 price target.
10/06/17
CLVD
10/06/17
UPGRADE
CLVD
Buy
Motorola Solutions upgraded to Buy from Neutral at Cleveland Research
08/31/17
JEFF
08/31/17
NO CHANGE
Target $105
JEFF
Buy
Motorola Solutions meetings support positive view, says Jefferies
Jefferies analyst George Notter says meetings with management reinforce his positive view on Motorola Solutions. The analyst has a Buy rating on the shares with a $105 price target. The company's Public Safety/LMR radio systems are thus far operating extremely well in the Houston area, while the cellular/LTE network in that area is currently experiencing significant outages after Hurricane Harvey, Notter tells investors in a research note. He believes the storm highlights the difference in reliability of LMR sites versus LTE cell sites. Further, based on his conversations, Notter finds it likely that Motorola Solutions' Airwave contract in the United Kingdom will continue to get renewed going forward. Airwave is becoming a bigger focus for investors as the LMR network contract is set to expire on December 13, 2019, the analyst contends.
05/30/17
NRCS
05/30/17
UPGRADE
NRCS
Buy
Motorola Solutions upgraded to Buy from Neutral at Northcoast

TODAY'S FREE FLY STORIES

ICUI

ICU Medical

$188.40

0.9 (0.48%)

05:20
10/17/17
10/17
05:20
10/17/17
05:20
Initiation
ICU Medical initiated  »

ICU Medical initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

NFLX

Netflix

$202.68

3.19 (1.60%)

05:17
10/17/17
10/17
05:17
10/17/17
05:17
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

EQT

EQT Corporation

$62.56

-0.45 (-0.71%)

, RICE

Rice Energy

$27.32

-0.2 (-0.73%)

05:17
10/17/17
10/17
05:17
10/17/17
05:17
Hot Stocks
EQT Corporation reiterates benefits of pending acquisition of Rice Energy »

EQT Corporation (EQT),…

EQT

EQT Corporation

$62.56

-0.45 (-0.71%)

RICE

Rice Energy

$27.32

-0.2 (-0.73%)

EQGP

EQT GP

$29.71

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 14

    Nov

  • 15

    May

  • 16

    May

NFLX

Netflix

$202.68

3.19 (1.60%)

05:12
10/17/17
10/17
05:12
10/17/17
05:12
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CMC

Commercial Metals

$20.50

-0.28 (-1.35%)

, GGB

Gerdau

$3.57

-0.01 (-0.28%)

05:11
10/17/17
10/17
05:11
10/17/17
05:11
Upgrade
Commercial Metals, Gerdau rating change  »

Commercial Metals…

CMC

Commercial Metals

$20.50

-0.28 (-1.35%)

GGB

Gerdau

$3.57

-0.01 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

SECO

Seeco Holding

$8.30

0.14 (1.72%)

05:07
10/17/17
10/17
05:07
10/17/17
05:07
Initiation
Seeco Holding initiated  »

Seeco Holding initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$198.41

-7.11 (-3.46%)

05:06
10/17/17
10/17
05:06
10/17/17
05:06
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

EV

Eaton Vance

$51.10

0.03 (0.06%)

05:02
10/17/17
10/17
05:02
10/17/17
05:02
Initiation
Eaton Vance initiated  »

Eaton Vance initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FII

Federated Investors

$31.48

0.2 (0.64%)

05:02
10/17/17
10/17
05:02
10/17/17
05:02
Initiation
Federated Investors initiated  »

Federated Investors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

JHG

Janus Henderson Group

$35.22

-0.08 (-0.23%)

05:01
10/17/17
10/17
05:01
10/17/17
05:01
Initiation
Janus Henderson Group initiated  »

Janus Henderson Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LM

Legg Mason

$37.63

-1.11 (-2.87%)

05:01
10/17/17
10/17
05:01
10/17/17
05:01
Initiation
Legg Mason initiated  »

Legg Mason initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

WETF

WisdomTree

$11.00

0.01 (0.09%)

05:00
10/17/17
10/17
05:00
10/17/17
05:00
Initiation
WisdomTree initiated  »

WisdomTree initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$15.27

0.52 (3.53%)

04:59
10/17/17
10/17
04:59
10/17/17
04:59
Downgrade
Freeport McMoRan rating change  »

Freeport McMoRan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ERJ

Embraer

$21.42

-0.63 (-2.86%)

, EADSY

Airbus

$22.75

-0.07 (-0.31%)

04:56
10/17/17
10/17
04:56
10/17/17
04:56
Downgrade
Embraer, Airbus rating change  »

Embraer downgraded to…

ERJ

Embraer

$21.42

-0.63 (-2.86%)

EADSY

Airbus

$22.75

-0.07 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$114.58

0.72 (0.63%)

, CSOD

Cornerstone OnDemand

$39.02

0.02 (0.05%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Stephens human capital management team holds analyst/industry conference call »

Enterprise Software…

ADP

ADP

$114.58

0.72 (0.63%)

CSOD

Cornerstone OnDemand

$39.02

0.02 (0.05%)

MSFT

Microsoft

$77.65

0.16 (0.21%)

ORCL

Oracle

$48.86

0.25 (0.51%)

PAYC

Paycom

$78.99

-0.9 (-1.13%)

PCTY

Paylocity

$50.08

0.17 (0.34%)

SAP

SAP

$111.84

-0.88 (-0.78%)

ULTI

Ultimate Software

$194.45

-3.47 (-1.75%)

WDAY

Workday

$107.23

-2.13 (-1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 22

    Oct

  • 26

    Oct

  • 31

    Oct

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 05

    Nov

  • 08

    Nov

  • 15

    Nov

WES

Western Gas Partners

$50.92

-0.38 (-0.74%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Western Gas Partners to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Stephens food & agribusiness analyst holds an analyst/industry conference call »

Food & Agribusiness…

SFNC

Simmons First National

$58.90

0.45 (0.77%)

, OKSB

Southwest Bancorp

$28.05

0.15 (0.54%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Southwest Bancorp to host special shareholder meeting »

Special Shareholder…

SFNC

Simmons First National

$58.90

0.45 (0.77%)

OKSB

Southwest Bancorp

$28.05

0.15 (0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 18

    Oct

  • 23

    Oct

CLSD

Clearside Biomedical

$7.77

0.03 (0.39%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Clearside Biomedical management to meet with JMP Securities »

Meetings to be held on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

AKR

Acadia Realty Trust

$30.26

-0.2 (-0.66%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Acadia Realty Trust management to meet with JPMorgan »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 03

    Nov

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Citigroup to hold a conference »

9th Annual Australian…

GSM

Ferroglobe

$14.56

0.39 (2.75%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Ferroglobe to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

  • 15

    Nov

CYTR

CytRx

$0.38

-0.0142 (-3.64%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
CytRx to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ESPR

Esperion

$52.98

-0.94 (-1.74%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Esperion to hold analyst and investor day »

Analyst and Investor Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 06

    Nov

TEVA

Teva

$14.71

-0.27 (-1.80%)

, MYL

Mylan

$38.18

0.23 (0.61%)

04:55
10/17/17
10/17
04:55
10/17/17
04:55
Conference/Events
Wells Fargo specialty pharma analyst holds an analyst/industry conference call »

Large-Cap & Specialty…

TEVA

Teva

$14.71

-0.27 (-1.80%)

MYL

Mylan

$38.18

0.23 (0.61%)

PRGO

Perrigo

$87.04

-0.74 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 02

    Nov

  • 03

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.